SNYDER DAVID S 4
4 · Coya Therapeutics, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
SNYDER DAVID S
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2023-01-03+7,000→ 7,000 total - Purchase
Warrant to Purchase Common Stock
2023-01-03+3,500→ 3,500 totalExercise: $7.50From: 2023-01-03Exp: 2025-01-03→ Common Stock, par value $0.0001 per share (3,500 underlying)
Footnotes (1)
- [F1]Reporting Person purchased 7,000 shares of Common Stock and an accompanying warrant to purchase 3,500 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant.